Urothelial Carcinoma With a Novel <i>MET</i> Exon 14 Skipping Alteration.

Cancer Diagn Progn · 2026 · PMC12758655 · PMID 41487928

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Despite its rarity, this alteration has highly significant implications for precision oncology.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Urothelial Carcinoma With a Novel &lt;i&gt;MET&lt;/i&gt; Exon 14 Skipping Alteration.

The sentences

Urothelial Carcinoma With a Novel <i>MET</i> Exon 14 Skipping Alteration.